Selon les derniers rapports financiers de Charles River Laboratories
, l'entreprise dispose de 0.19 Milliard d'euros en trésorerie et équivalents de trésorerie.
La trésorerie d'une entreprise, également appelée équivalents de trésorerie (CCE) et investissements à court terme, est le montant d'argent accessible qu'une entreprise possède.
Année | Trésorerie | Changement |
---|---|---|
2024-12-31 | €0.18 Md | -25.31% |
2023-12-31 | €0.25 Md | 14.81% |
2022-12-31 | €0.21 Md | 2.38% |
2021-12-31 | €0.21 Md | 14.18% |
2020-12-31 | €0.18 Md | -12.55% |
2019-12-31 | €0.21 Md | 24.29% |
2018-12-31 | €0.17 Md | 7.09% |
2017-12-31 | €0.16 Md | 38.85% |
2016-12-31 | €0.11 Md | -8.86% |
2015-12-31 | €0.12 Md | -12.59% |
2014-12-31 | €0.14 Md | 19.74% |
2013-12-31 | €0.12 Md | 37.41% |
2012-12-31 | €88.04 M | 53.97% |
2011-12-31 | €57.18 M | -59.75% |
2010-12-31 | €0.14 Md | -14.47% |
2009-12-31 | €0.16 Md | -4.66% |
2008-12-31 | €0.17 Md | 5.83% |
2007-12-31 | €0.16 Md | 18.83% |
2006-12-31 | €0.13 Md | 40.89% |
2005-12-31 | €98.34 M | -35.8% |
2004-12-31 | €0.15 Md | -1.34% |
2003-12-31 | €0.15 Md | 32.49% |
2002-12-31 | €0.11 Md | 77.62% |
2001-12-31 | €65.98 M | 87.62% |
2000-12-31 | €35.16 M | 135.76% |
1999-12-31 | €14.91 M | -28.66% |
1998-12-31 | €20.9 M |
Entreprise | Trésorerie | différencediff. | Pays |
---|---|---|---|
![]() Repligen
RGEN | €0.60 Md | 203.99% | 🇺🇸 USA |
![]() SCYNEXIS SCYX | €35.14 M | -82.30% | 🇺🇸 USA |
![]() Thermo Fisher Scientific TMO | €5.14 Md | 2,492.91% | 🇺🇸 USA |